Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

NCT04293289

Conditions: Angiosarcoma, Hemangiosarcoma, Malignant Melanoma, +15 more
Locations: National Cancer Center Hospital Chuo Ku, Tokyo, Japan

View Trial Details

Completed

Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma

NCT05714371

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Novartis Pharmaceuticals East Hanover, New Jersey, United States

View Trial Details

Completed

Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

NCT02959905

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +19 more
Locations: Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

NCT01607905

Conditions: Adenocarcinoma, Astrocytoma, Carcinoma, +28 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Karmanos Cancer Institute Detroit, Michigan, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Gabrail Cancer Center Canton, Ohio, United States

View Trial Details

Completed

Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma

NCT02032810

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma

NCT01657591

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

NCT04430842

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations: St George Private Hospital Kogarah, New South Wales, Australia

Sydney Southwest Private Hospital Liverpool, New South Wales, Australia

View Trial Details

Completed

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

NCT01176461

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

NCT01993719

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI)

NCT02307149

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: City of Hope National Medical Center, Duarte, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

The Angeles Clinic & Research Institute Los Angeles, California, United States

John Wayne Cancer Institute Santa Monica, California, United States

View Trial Details